Monoswift®
Monofilament PGCL 25 Synthetic Absorbable
Characteristics
-
Excellent holding strength
-
Monoswift smooth tissue passage has excellent handling, exceptional suppleness, and good knot security
-
Non-wicking helps prevent bacterial migration along suture line
Indications
PGCL synthetic absorbable monofilament sutures are indicated for use in soft tissue approximation and/or ligation, but not for use in cardiovasular or neurological surgery, microsurgery, or ophthalmic surgery.
Actions
PGCL synthetic absorbable monofilament suture elicts a minimal acute inflammatory reaction in tissues, followed by gradual encapsulation of the suture by fibrous connective tissue. Progressive loss of tensile strength and eventual absorptions of PGCL synthetic absorbable monofilament suture occurs by means of hydrolysis.
Tensile Stregth
Implantation studies in animal indicate that PGCL suture retains approximately 70% to 80% of its origional tensile strength at 7 days post implantation and approximately 40% of its origional tensile strength at 14 days post implantation.


